Etanercept does not impede normal height and weight development in these patients
Shingles, Chickenpox Hospitalizations Higher for Patients on Anti-TNF Drugs
More research needed to clarify risks and benefits of VZV vaccination
Can Technology Help Solve Scleroderma Renal Crisis?
A case study in using the Internet to facilitate rare disease research
ACR Honors Accomplishments in Rheumatology
Rheumatologists and health professionals recognized for their contributions to the field
Naturally Occurring Antibodies May Lead to New RA Therapies
A study published in the Journal of Immunology indicates that naturally occurring antibodies in the human immune system have the capacity to suppress inflammatory responses throughout the body. These antibodies may provide researchers an opportunity to develop new therapies for rheumatoid arthritis (RA) and other inflammatory conditions using similar pathways.
Rheum with a View
Panush’s perspectives on selections from the literature
“A Common Language for Spondyloarthritis”
ASAS fills a niche, changes dogma with consensus approach
Arthritis on the Rise
CDC notes significant increase in arthritis-attributable activity limitation
For Myopathy Basic Diagnostic Rules Hold
Rare and challenging, idiopathic inflammatory myopathies are gaining from collaborative research
Research Tracks Possible Benefit of Src-like Adaptor Protein
A study recently submitted for publication has demonstrated that manipulating T-cell receptor complex–mediated signaling can prevent the development of autoimmune arthritis in mice and may lead to new human therapies without the drawbacks associated with existing treatments.
- « Previous Page
- 1
- …
- 102
- 103
- 104
- 105
- 106
- …
- 123
- Next Page »